Clinical Trial Update: Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating indacaterol versus placebo in maintenance-naïve patients with chronic obstructive pulmonary disease, using blinded tiotropium as an a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)
• tiotropium (tiotropium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: WITHDRAWN